Week 12/05/2004 through 12/12/2004

Prepared by: Dante Fichera, CPA

What’s Hot this reporting period are venture backed companies based in California operating in the Biotechnology industry and that have raised their Series C round of financing.

On Wall Street CapitalHunter.com identified the following IPO’s:

1. Adeza Biomedical had its initial public offering this week for $60 million and trades under the ticker ADZA.
2. Bill Barrett had its initial public offering this week for $1,018 million and trades under the ticker BBG.
3. Community Bancorp had its initial public offering this week for $53 million and trades under the ticker CBON.
4. Foundation Coal Holdings had its initial public offering this week for $519 million and trades under the ticker FCL.
5. Occulogix had its initial public offering this week for $101 million and trades under the ticker RHEO.
6. Symmetry Medical had its initial public offering this week for $120 million and trades under the ticker SMA.
7. CABG Medical had its initial public offering this week for $30 million and trades under the ticker CABG.

CapitalHunter.com was able to verify that $323 million of venture capital was invested in 25 U.S.-based companies during this week’s reporting period. The average deal size was approximately $12.92 million. The amount of venture capital invested this period increased by 9% from last week’s $297 million.

Geographically,9 California companies raised $62.24 million in venture financings. The largest private venture financing in California this period was into Sequoia Communications who raised $15 million. Sequoia Communications is a San Diego based company that develops highly integrated multi-mode RFICs for the mobile handset market.

The biotechnology sector raised 35% of the venture capital this period. Four biotechnology companies raised $112.6 million in venture financing. The largest private venture financing in the biotechnology sector this period was into Prestwick Pharmaceuticals who raised $37 million. Prestwick Pharmaceuticals is a Washington DC based company engaged in the development and marketing of drugs for diseases of the central nervous system.

Companies raising their Series C round of financing led this week’s venture capital activity. Series C financings represented 47% of the total venture capital deployed this period. The largest Series C financing was into Prestwick Pharmaceuticals.

The three largest venture deals this period are as follows:

The following nine and other unnamed investors funded the above mentioned top three venture capital investments for $110 Million:

A total of 58 worldwide equity financings of private and public companies occurred during this reporting period. Each of the 58 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.

About CapitalHunter.com

CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.

Please visit www.capitalhunter.com and get immediate access. New subscribers can request a free investor analysis.

To be REMOVED from this free service, CLICK HERE